Cochlear Implants Offer Revenue Stream for Private Practice Audiologists

Chuck Holt
{"title":"Cochlear Implants Offer Revenue Stream for Private Practice Audiologists","authors":"Chuck Holt","doi":"10.1097/01.hj.0000947692.55079.11","DOIUrl":null,"url":null,"abstract":"Since cochlear implants were approved by the FDA for adults with bilateral hearing loss in 1985, the external and internal components have undergone significant technological improvements.www.shutterstock.com. Cochlear implants, cochlear provider network.Over time, every component of the external system of a cochlear implant has seen upgrades, from the magnets and microphones that capture acoustic signals to speech processors that transform sounds into electrical signals sent to the nerve fibers of the cochlea. The internal portion of the device consists of a receiver-stimulator and electrode array that offer better control of electrical signals that stimulate the cochlea and provide patients with more detailed pitch and improved loudness. Some cochlear implant manufacturers also offer FDA-approved bone-conduction devices for patients with conductive hearing loss, mixed hearing loss, and single-sided deafness. The bone-conduction device uses different technology than the cochlear implant, in that, instead of transmitting electrical signals to the auditory nerve the acoustic signal is transduced into vibrations to stimulate the inner ear directly. Because of the ongoing technological advances, more patients are candidates for an implanted hearing loss treatment than ever before. Yet, only a fraction of eligible patients have undergone the surgery—less than 10%, in fact, by most estimates. “The thing that has me concerned is that penetration is still very low,” said Dr. William Shapiro, AuD, CCC-A, Co-Director of the New York University (NYU) Langone Health Cochlear Implant Center. The problem, he said, “is paradoxical.” “As technology improves and the criteria for selection expands, more individuals with hearing loss become candidates for cochlear implants—but we’re not getting to them,” he continued. “And so we need to do a much better job of raising awareness, which is why I say it’s paradoxical. Because although we have better technology, we aren’t reaching the number of patients we need to serve.” To help increase patient awareness and adoption of cochlear implants, Shapiro serves as a liaison of sorts between the community audiologists and the cochlear provider network (CPN) of the world’s largest manufacturer of surgical implants for hearing loss, Cochlear Limited. The relationships portend more CI surgeries to benefit the private practitioner, the Implant Center, and mostly importantly the patient. This, of course depends on the degree of buy-in by the private practitioner, Shapiro said. The buy-in varies from audiologist to audiologist. “Some audiologists in private practice just want to be able to explain the benefits of a trusted treatment and give them some CI brochures,” he said. “And then other audiologists want to be involved in all aspects of the cochlear implant process.” “These are the audiologists who want to do the pre- and post-operative testing,” he continued. “They want to refer their patients to our surgeon, and then have us refer the patient back to them for the post-op programming.” A TRIANGLE OF TRUST NYU has relationships with private practice audiologists all around the New York City tri-state metro area, east to Long Island and throughout Manhattan. The CPN has provided NYU with a group of local audiologists vetted based on several factors, including their familiarity with CIs and their desire “to offer their patients every available treatment option for hearing loss,” Shapiro said. There are no set criteria a private practice audiologist must meet to partner with NYU and the CPN, apart from following “all good clinical practice guidelines,” he said. “Certainly, we want them to have been in the field for a certain number of years, have a loyal patient following, and are comfortable partnering with a hospital,” Shapiro added. “There has to be a real level of trust in the audiologist,” he continued. “And it is difficult because we are going to be doing surgery based on the results that they give us, so we have to be very careful about that.” Ongoing communication is important. “Private practice audiologists will call and say, ‘Hey, I have this patient. I will email you their results. Can you tell me what you think?’” he shared. “And so we have this impromptu conference about a patient, after which I will say to them, ‘OK, why don’t you go ahead and start the pre-op testing,’” he continued. “So there’s kind of a triangle created between the CPN, the Cochlear Implant Center, and the private practice audiologist who all work together with open communication in the best interest of the patient.” INTERPRETING THE RELATIONSHIP A profile of the audiologist partner most likely to succeed has begun to emerge, Shapiro said. “These are audiologists who are open to another revenue stream other than hearing aids,” he said. “Additionally, they want to be looked at in the community as a hearing health expert who offers patients all of the latest solutions.” A local audiologist who can handle all aspects short of CI surgery is especially helpful, for example, to patients who live a long way from the implant center at NYU, Shapiro noted. “Audiologists have many tools in their toolbox. And there are a lot of very good practitioners out there who want to be able to present to their patients the full array of solutions to their patients’ hearing problems,” he said. “And it has been my experience that the local audiologist has a lot of very loyal patients who are more likely to listen to them when they say, ‘I think you are a good candidate for a cochlear implant.’” The surgeon, meanwhile, needs to have a willingness to communicate openly with audiologists and also recognize the value of the entire care team. “Cochlear implants are a very interesting treatment in that they involve a multidisciplinary approach to delivering patient care,” Shapiro said. “Nowhere else in otolaryngology do you see that sort of team effort, and so it’s important that the surgeon is supportive of the audiology team.” After entering a relationship with a local audiologist, Shapiro serves as a liaison with the CI surgeon. “It’s not that the audiologist can’t speak directly to the surgeon, but I serve as the interpreter,” he said. Like any relationship, good communication is paramount, Shapiro noted. “The relationship is going to wax and wane. Sometimes we have more referrals in a 3-month period, and sometimes less,” he said. “And so, like any relationship, it is important to check in and say, ‘Hey, I haven’t heard from you in a while. Is there anything you need?’” Recently, NYU started a relationship with a second CPN, which has no conflict with the initial CPN as they are in geographically different areas. For private practice audiologists, however, “it’s probably not a good idea to offer all three FDA-approved devices,” Shapiro offered. “Although our surgeon can implant all of them, you need to be able to program it. So it’s always good to start off with just one device and then go from there.” A WINNING SCENARIO Despite stubbornly low adoption rates, CIs have become much more mainstream, while the internet has influenced patient’s expectations, said Shapiro, who has been a practicing audiologist since 1978. “When we first started working with cochlear implants, they were investigational devices and we took a lot of time seeing our patients and testing them,” he said. “Now, because of financial concerns and therefore increased need for efficiency, we don’t see our patients as much as we used to. But they are coming in with a greater idea of what a cochlear implant can do.” Audiologists also know a lot more now about what the devices can do for patients, Shapiro said. “We didn’t know what we could expect from cochlear implants back in the early ´80s,” he said. “If a patient could tell the difference between a noise and a voice, or a question and a statement, or a male voice from a female voice, then we didn’t implant them.” “It wasn’t a matter of them understanding something, because they didn’t understand anything,” he clarified. “And so if they could hear the difference between these things, then we thought that they weren’t a candidate because we didn’t really know what we could provide them with.” Today, NYU hosts community meetings and schedules other special events regularly to help increase public awareness about advances in CI systems and also share information with interested local audiologists and those who might never have considered the benefits of partnering with a hospital-based surgical center. “The CPNs need to be able to talk to these local audiologists to explain to them that there are many more patients out there who are candidates for CI now who haven’t been in the past few years,” said Shapiro. “And it’s changing constantly. But again, the part that is paradoxical and a little bit concerning to me is that our penetration is low and getting worse as technology expands.” Any number of reasons might explain why CIs are not as popular as might be expected—from primary care providers being unaware of the widening selection criteria for the treatment, to competition from technologically advanced hearing aids, or just the fear of surgery. “Whatever the reason is for that, we need to increase patient access to cochlear implants, which is at the core of what we are trying to do in building a provider network,” Shapiro said. “It’s good for the patient, it’s good for the manufacturer, it’s good for the cochlear center, and it’s good for the audiologist in private practice. It’s a win, win, win, win for everyone!”","PeriodicalId":39705,"journal":{"name":"Hearing Journal","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hearing Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.hj.0000947692.55079.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Since cochlear implants were approved by the FDA for adults with bilateral hearing loss in 1985, the external and internal components have undergone significant technological improvements.www.shutterstock.com. Cochlear implants, cochlear provider network.Over time, every component of the external system of a cochlear implant has seen upgrades, from the magnets and microphones that capture acoustic signals to speech processors that transform sounds into electrical signals sent to the nerve fibers of the cochlea. The internal portion of the device consists of a receiver-stimulator and electrode array that offer better control of electrical signals that stimulate the cochlea and provide patients with more detailed pitch and improved loudness. Some cochlear implant manufacturers also offer FDA-approved bone-conduction devices for patients with conductive hearing loss, mixed hearing loss, and single-sided deafness. The bone-conduction device uses different technology than the cochlear implant, in that, instead of transmitting electrical signals to the auditory nerve the acoustic signal is transduced into vibrations to stimulate the inner ear directly. Because of the ongoing technological advances, more patients are candidates for an implanted hearing loss treatment than ever before. Yet, only a fraction of eligible patients have undergone the surgery—less than 10%, in fact, by most estimates. “The thing that has me concerned is that penetration is still very low,” said Dr. William Shapiro, AuD, CCC-A, Co-Director of the New York University (NYU) Langone Health Cochlear Implant Center. The problem, he said, “is paradoxical.” “As technology improves and the criteria for selection expands, more individuals with hearing loss become candidates for cochlear implants—but we’re not getting to them,” he continued. “And so we need to do a much better job of raising awareness, which is why I say it’s paradoxical. Because although we have better technology, we aren’t reaching the number of patients we need to serve.” To help increase patient awareness and adoption of cochlear implants, Shapiro serves as a liaison of sorts between the community audiologists and the cochlear provider network (CPN) of the world’s largest manufacturer of surgical implants for hearing loss, Cochlear Limited. The relationships portend more CI surgeries to benefit the private practitioner, the Implant Center, and mostly importantly the patient. This, of course depends on the degree of buy-in by the private practitioner, Shapiro said. The buy-in varies from audiologist to audiologist. “Some audiologists in private practice just want to be able to explain the benefits of a trusted treatment and give them some CI brochures,” he said. “And then other audiologists want to be involved in all aspects of the cochlear implant process.” “These are the audiologists who want to do the pre- and post-operative testing,” he continued. “They want to refer their patients to our surgeon, and then have us refer the patient back to them for the post-op programming.” A TRIANGLE OF TRUST NYU has relationships with private practice audiologists all around the New York City tri-state metro area, east to Long Island and throughout Manhattan. The CPN has provided NYU with a group of local audiologists vetted based on several factors, including their familiarity with CIs and their desire “to offer their patients every available treatment option for hearing loss,” Shapiro said. There are no set criteria a private practice audiologist must meet to partner with NYU and the CPN, apart from following “all good clinical practice guidelines,” he said. “Certainly, we want them to have been in the field for a certain number of years, have a loyal patient following, and are comfortable partnering with a hospital,” Shapiro added. “There has to be a real level of trust in the audiologist,” he continued. “And it is difficult because we are going to be doing surgery based on the results that they give us, so we have to be very careful about that.” Ongoing communication is important. “Private practice audiologists will call and say, ‘Hey, I have this patient. I will email you their results. Can you tell me what you think?’” he shared. “And so we have this impromptu conference about a patient, after which I will say to them, ‘OK, why don’t you go ahead and start the pre-op testing,’” he continued. “So there’s kind of a triangle created between the CPN, the Cochlear Implant Center, and the private practice audiologist who all work together with open communication in the best interest of the patient.” INTERPRETING THE RELATIONSHIP A profile of the audiologist partner most likely to succeed has begun to emerge, Shapiro said. “These are audiologists who are open to another revenue stream other than hearing aids,” he said. “Additionally, they want to be looked at in the community as a hearing health expert who offers patients all of the latest solutions.” A local audiologist who can handle all aspects short of CI surgery is especially helpful, for example, to patients who live a long way from the implant center at NYU, Shapiro noted. “Audiologists have many tools in their toolbox. And there are a lot of very good practitioners out there who want to be able to present to their patients the full array of solutions to their patients’ hearing problems,” he said. “And it has been my experience that the local audiologist has a lot of very loyal patients who are more likely to listen to them when they say, ‘I think you are a good candidate for a cochlear implant.’” The surgeon, meanwhile, needs to have a willingness to communicate openly with audiologists and also recognize the value of the entire care team. “Cochlear implants are a very interesting treatment in that they involve a multidisciplinary approach to delivering patient care,” Shapiro said. “Nowhere else in otolaryngology do you see that sort of team effort, and so it’s important that the surgeon is supportive of the audiology team.” After entering a relationship with a local audiologist, Shapiro serves as a liaison with the CI surgeon. “It’s not that the audiologist can’t speak directly to the surgeon, but I serve as the interpreter,” he said. Like any relationship, good communication is paramount, Shapiro noted. “The relationship is going to wax and wane. Sometimes we have more referrals in a 3-month period, and sometimes less,” he said. “And so, like any relationship, it is important to check in and say, ‘Hey, I haven’t heard from you in a while. Is there anything you need?’” Recently, NYU started a relationship with a second CPN, which has no conflict with the initial CPN as they are in geographically different areas. For private practice audiologists, however, “it’s probably not a good idea to offer all three FDA-approved devices,” Shapiro offered. “Although our surgeon can implant all of them, you need to be able to program it. So it’s always good to start off with just one device and then go from there.” A WINNING SCENARIO Despite stubbornly low adoption rates, CIs have become much more mainstream, while the internet has influenced patient’s expectations, said Shapiro, who has been a practicing audiologist since 1978. “When we first started working with cochlear implants, they were investigational devices and we took a lot of time seeing our patients and testing them,” he said. “Now, because of financial concerns and therefore increased need for efficiency, we don’t see our patients as much as we used to. But they are coming in with a greater idea of what a cochlear implant can do.” Audiologists also know a lot more now about what the devices can do for patients, Shapiro said. “We didn’t know what we could expect from cochlear implants back in the early ´80s,” he said. “If a patient could tell the difference between a noise and a voice, or a question and a statement, or a male voice from a female voice, then we didn’t implant them.” “It wasn’t a matter of them understanding something, because they didn’t understand anything,” he clarified. “And so if they could hear the difference between these things, then we thought that they weren’t a candidate because we didn’t really know what we could provide them with.” Today, NYU hosts community meetings and schedules other special events regularly to help increase public awareness about advances in CI systems and also share information with interested local audiologists and those who might never have considered the benefits of partnering with a hospital-based surgical center. “The CPNs need to be able to talk to these local audiologists to explain to them that there are many more patients out there who are candidates for CI now who haven’t been in the past few years,” said Shapiro. “And it’s changing constantly. But again, the part that is paradoxical and a little bit concerning to me is that our penetration is low and getting worse as technology expands.” Any number of reasons might explain why CIs are not as popular as might be expected—from primary care providers being unaware of the widening selection criteria for the treatment, to competition from technologically advanced hearing aids, or just the fear of surgery. “Whatever the reason is for that, we need to increase patient access to cochlear implants, which is at the core of what we are trying to do in building a provider network,” Shapiro said. “It’s good for the patient, it’s good for the manufacturer, it’s good for the cochlear center, and it’s good for the audiologist in private practice. It’s a win, win, win, win for everyone!”
人工耳蜗为私人执业听力学家提供收入来源
自1985年美国食品和药物管理局批准为双侧听力损失的成年人植入人工耳蜗以来,其外部和内部部件经历了重大的技术改进。www.shutterstock.com。人工耳蜗,人工耳蜗提供者网络。随着时间的推移,人工耳蜗外部系统的每个部件都得到了升级,从捕捉声音信号的磁铁和麦克风,到将声音转换成电信号发送到耳蜗神经纤维的语音处理器。该装置的内部部分由一个接收器-刺激器和电极阵列组成,可以更好地控制刺激耳蜗的电信号,并为患者提供更详细的音高和更高的响度。一些人工耳蜗制造商也为传导性听力损失、混合性听力损失和单侧耳聋患者提供经fda批准的骨传导装置。骨传导装置使用的技术与人工耳蜗不同,它不是将电信号传递给听神经,而是将声信号转化为振动,直接刺激内耳。由于技术的不断进步,比以往任何时候都有更多的患者是植入式听力损失治疗的候选人。然而,只有一小部分符合条件的患者接受了手术——事实上,根据大多数估计,不到10%。纽约大学兰格尼健康人工耳蜗中心联合主任威廉·夏皮罗博士说:“让我担心的是,人工耳蜗的普及率仍然很低。”他说,这个问题“自相矛盾”。“随着技术的进步和选择标准的扩大,越来越多的听力损失患者成为人工耳蜗植入的候选人,但我们还没有找到他们,”他继续说。“因此,我们需要在提高意识方面做得更好,这就是为什么我说这是矛盾的。因为尽管我们有更好的技术,但我们还没有达到我们需要服务的病人数量。”为了帮助提高患者对人工耳蜗的认知度和认知度,夏皮罗在社区听科学家和世界上最大的耳蜗植入手术制造商cochlear Limited的人工耳蜗供应商网络(CPN)之间担任各种联络人。这种关系预示着更多的CI手术将造福私人医生、种植中心,最重要的是病人。夏皮罗说,这当然取决于私人医生的接受程度。每个听力学家的支持都不一样。他说:“一些私人执业的听力学家只是希望能够解释一种值得信赖的治疗方法的好处,并给他们一些CI手册。”“然后其他听力学家希望参与人工耳蜗植入过程的各个方面。“这些听力学家想做术前和术后测试,”他继续说。“他们想把他们的病人推荐给我们的外科医生,然后让我们把病人推荐给他们进行术后规划。”纽约大学与纽约市三州都会区(东至长岛和整个曼哈顿)的私人执业听力学家都有联系。夏皮罗说,CPN为纽约大学提供了一批当地听力学家,这些听力学家是根据几个因素进行审查的,包括他们对ci的熟悉程度,以及他们“为听力损失患者提供所有可用的治疗选择”的愿望。他说,私人执业听力学家要与纽约大学和CPN合作,除了遵循“所有良好的临床实践指南”外,没有既定的标准。夏皮罗补充说:“当然,我们希望他们在这个领域已经工作了一定的时间,拥有忠实的病人,并且愿意与医院合作。”“必须对听力学家有真正程度的信任,”他继续说。“这很困难,因为我们将根据他们给我们的结果进行手术,所以我们必须非常小心。”持续的沟通很重要。“私人听力学家会打电话说,‘嘿,我有个病人。我会把结果发邮件给你。你能告诉我你的想法吗?’”他分享道。“所以我们会为一个病人开一个临时会议,会后我会对他们说,‘好吧,你们为什么不开始术前测试呢,’”他继续说。“因此,在CPN、人工耳蜗植入中心和私人执业听力学家之间形成了一种三角关系,他们都为了患者的最大利益而共同努力,进行开放的沟通。”夏皮罗说,最有可能成功的听力专家伴侣的概况已经开始显现。“这些听力学家对助听器以外的其他收入来源持开放态度,”他说。“此外,他们希望在社区中被视为听力健康专家,为患者提供所有最新的解决方案。 夏皮罗指出,当地的听力学家可以处理CI手术以外的所有方面,例如,对于离纽约大学植入中心很远的患者来说,这尤其有帮助。“听力学家的工具箱里有很多工具。有很多非常优秀的医生,他们希望能够向他们的病人提供解决他们病人听力问题的全套解决方案。”“根据我的经验,当地的听力学家有很多非常忠诚的病人,当他们说‘我认为你是植入人工耳蜗的好人选’时,他们更有可能听他们的话。与此同时,外科医生需要愿意与听力学家公开交流,并认识到整个护理团队的价值。夏皮罗说:“人工耳蜗是一种非常有趣的治疗方法,因为它涉及到提供病人护理的多学科方法。”“在耳鼻喉科的其他地方,你看不到这种团队合作,所以外科医生支持听力学团队是很重要的。”在与当地的听力学家建立关系后,夏皮罗担任了与CI外科医生的联络人。“并不是听力学家不能直接和外科医生说话,而是我充当翻译,”他说。夏皮罗指出,像任何关系一样,良好的沟通是至关重要的。“这种关系会有起起落落。有时我们在3个月内会收到更多的转诊,有时会更少。”“所以,就像任何关系一样,重要的是要互相问候,并说,‘嘿,我有一段时间没有你的消息了。你需要什么吗?最近,纽约大学开始与第二个CPN建立关系,这与最初的CPN没有冲突,因为它们位于不同的地理区域。然而,对于私人执业的听力学家来说,“提供所有三种fda批准的设备可能不是一个好主意,”夏皮罗说。“虽然我们的外科医生可以植入所有这些,但你需要能够对其进行编程。所以最好从一款设备开始,然后从那里开始。”自1978年以来一直是听力学家的夏皮罗说,尽管采用率一直很低,但人工耳蜗已经变得越来越主流,而互联网也影响了病人的期望。他说:“当我们第一次开始研究人工耳蜗时,它们还是试验性设备,我们花了很多时间去看病人并对它们进行测试。”“现在,由于财政方面的考虑,以及因此对效率的需求增加,我们不像以前那样经常看病人。但他们对人工耳蜗的作用有了更深入的了解。”夏皮罗说,听力学家现在也对这些设备能为病人做些什么有了更多的了解。“早在80年代初,我们并不知道人工耳蜗能带来什么,”他说。“如果病人能分辨噪音和声音、问题和陈述、男声和女声,那么我们就不会植入它们。“这不是他们理解什么的问题,因为他们什么都不理解,”他澄清道。“因此,如果他们能听出这些东西之间的区别,那么我们就认为他们不是候选人,因为我们真的不知道我们能为他们提供什么。”今天,纽约大学定期举办社区会议和安排其他特别活动,以帮助提高公众对CI系统进展的认识,并与感兴趣的当地听力学家和那些可能从未考虑过与医院外科中心合作的人分享信息。夏皮罗说:“cpn需要能够与当地的听力学家交谈,向他们解释,现在有更多的病人在过去的几年里没有接受过颅内炎的治疗。”“它在不断变化。但是,同样矛盾的是,我们的普及率很低,而且随着技术的发展,普及率越来越低,这让我有点担心。”有很多原因可以解释为什么ci不像预期的那样受欢迎——从初级保健提供者不知道治疗选择标准的扩大,到来自技术先进的助听器的竞争,或者仅仅是对手术的恐惧。夏皮罗说:“无论原因是什么,我们都需要增加患者获得人工耳蜗的机会,这是我们努力建立供应商网络的核心。”“这对病人有利,对制造商有利,对耳蜗中心有利,对私人执业的听力学家也有利。这是双赢,双赢,双赢,对每个人都是双赢!”
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hearing Journal
Hearing Journal Health Professions-Speech and Hearing
CiteScore
0.50
自引率
0.00%
发文量
112
期刊介绍: Established in 1947, The Hearing Journal (HJ) is the leading trade journal in the hearing industry, reaching more than 22,000 hearing healthcare professionals. Each month, the Journal provides readers with accurate, timely, and practical information to help them in their practices. Read HJ to find out about the latest developments in patient care, technology, practice management, and professional issues. Popular monthly features include the Cover Story, Page Ten, Nuts & Bolts, HJ Report, and the Final Word.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信